Empowered Funds’s Xtant Medical Holdings XTNT Stock Holding History

Empowered Funds’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$24.5K	Buy	+69,100	New	+$26.5K	﹤0.01%	2507

Other funds holding XTNT

Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return

AIC

AWM Investment Company New York $1.04B AUM 103.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.18B AUM 13.12% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $140M AUM 44.76% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return

Wiregrass Investment Management Thomasville, Georgia $144M AUM 19.4% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Empowered Funds's XTNT Position: Q3 2026 in Review

Empowered Funds opened a new position in Xtant Medical Holdings (XTNT) in Q3 2026: 69,100 shares worth $24.5K. The stake represents ﹤0.01% of the portfolio and ranks #2507 among its holdings.

24 funds tracked by Wall St. Rank hold XTNT as of Q3 2026.

Empowered Funds held 69,100 shares of Xtant Medical Holdings worth $24.5K as of Q3 2026.
Xtant Medical Holdings was a new Empowered Funds position in Q3 2026.
Xtant Medical Holdings made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2507 holding.
24 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.